日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure

IL-1β 抗体 Gevokizumab 可限制心力衰竭大鼠的心脏重塑和冠状动脉功能障碍

期刊:Jacc-Basic To Translational Science
影响因子:7.2
doi:10.1016/j.jacbts.2017.06.005
Harouki, Najah; Nicol, Lionel; Remy-Jouet, Isabelle; Henry, Jean-Paul; Dumesnil, Anais; Lejeune, Annie; Renet, Sylvanie; Golding, Francesca; Djerada, Zoubir; Wecker, Didier; Bolduc, Virginie; Bouly, Muriel; Roussel, Jerome; Richard, Vincent; Mulder, Paul
Rat
IL-1β
心力衰竭
心血管
发表日期：2017
文献求助 收藏

Heterologous expression of the N-acetylglucosaminyltransferase I dictates a reinvestigation of the N-glycosylation pathway in Chlamydomonas reinhardtii

N-乙酰氨基葡萄糖转移酶I的异源表达决定了对莱茵衣藻中N-糖基化途径的重新研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-017-10698-z
Vanier, Gaëtan; Lucas, Pierre-Louis; Loutelier-Bourhis, Corinne; Vanier, Jessica; Plasson, Carole; Walet-Balieu, Marie-Laure; Tchi-Song, Philippe Chan; Remy-Jouet, Isabelle; Richard, Vincent; Bernard, Sophie; Driouich, Azeddine; Afonso, Carlos; Lerouge, Patrice; Mathieu-Rivet, Elodie; Bardor, Muriel
发表日期：2017
文献求助 收藏

Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.

可溶性环氧化物水解酶抑制剂可改善肥胖胰岛素抵抗小鼠的冠状动脉内皮功能，并防止心脏病变的发生

期刊:American Journal of Physiology-Heart and Circulatory Physiology
影响因子:4.1
doi:10.1152/ajpheart.00465.2014
Roche Clothilde, Besnier Marie, Cassel Roméo, Harouki Najah, Coquerel David, Guerrot Dominique, Nicol Lionel, Loizon Emmanuelle, Remy-Jouet Isabelle, Morisseau Christophe, Mulder Paul, Ouvrard-Pascaud Antoine, Madec Anne-Marie, Richard Vincent, Bellien Jeremy
心血管
发表日期：2015
文献求助 收藏